CD44 and cancer: Upregulation of other cancer-associated genes in MPOSE – such as Ccnd1, Btc, Ankrd1, Oraov1, Cd44 and Ifitm3 – as well as possible DNA mutations or fusions, may also contribute to tumorigenic differences and warrant further investigation.